JP2017537888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537888A5 JP2017537888A5 JP2017522654A JP2017522654A JP2017537888A5 JP 2017537888 A5 JP2017537888 A5 JP 2017537888A5 JP 2017522654 A JP2017522654 A JP 2017522654A JP 2017522654 A JP2017522654 A JP 2017522654A JP 2017537888 A5 JP2017537888 A5 JP 2017537888A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- fusion protein
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/524,832 | 2014-10-27 | ||
| US14/524,832 US10400029B2 (en) | 2011-06-28 | 2014-10-27 | Serpin fusion polypeptides and methods of use thereof |
| PCT/US2015/057533 WO2016069574A1 (en) | 2014-10-27 | 2015-10-27 | Serpin fusion polypeptides and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121953A Division JP2020180157A (ja) | 2014-10-27 | 2020-07-16 | セルピン融合ポリペプチド及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537888A JP2017537888A (ja) | 2017-12-21 |
| JP2017537888A5 true JP2017537888A5 (enExample) | 2018-10-25 |
| JP6737781B2 JP6737781B2 (ja) | 2020-08-12 |
Family
ID=55858243
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017522654A Active JP6737781B2 (ja) | 2014-10-27 | 2015-10-27 | セルピン融合ポリペプチド及びその使用方法 |
| JP2020121953A Pending JP2020180157A (ja) | 2014-10-27 | 2020-07-16 | セルピン融合ポリペプチド及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020121953A Pending JP2020180157A (ja) | 2014-10-27 | 2020-07-16 | セルピン融合ポリペプチド及びその使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP3212290A4 (enExample) |
| JP (2) | JP6737781B2 (enExample) |
| KR (2) | KR20170091096A (enExample) |
| CN (2) | CN107206257A (enExample) |
| AU (3) | AU2015339507B2 (enExample) |
| BR (1) | BR112017008525A2 (enExample) |
| CA (1) | CA2965151A1 (enExample) |
| HK (1) | HK1244460A1 (enExample) |
| IL (2) | IL251799B2 (enExample) |
| MX (2) | MX2017005467A (enExample) |
| NZ (1) | NZ769391A (enExample) |
| RU (1) | RU2746550C2 (enExample) |
| SG (2) | SG10201903142RA (enExample) |
| UA (1) | UA127305C2 (enExample) |
| WO (1) | WO2016069574A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020092448A1 (en) * | 2018-10-29 | 2020-05-07 | Spin Therapeutics, Llc | Compositions and methods for alpha-1-antitrypsin disorders |
| WO2020097946A1 (zh) * | 2018-11-18 | 2020-05-22 | 杭州博虎生物科技有限公司 | 一种重组人白细胞介素10融合蛋白及其应用 |
| US12649769B2 (en) | 2019-09-16 | 2026-06-09 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Recombinant human neuregulin derivatives and use thereof |
| CN112315897A (zh) * | 2020-11-04 | 2021-02-05 | 深圳前海鹰岗生物科技有限公司 | 一种抑制细胞炎症反应释放治疗痛风急性发作的聚合物微针及制备方法 |
| WO2022133521A1 (en) * | 2020-12-21 | 2022-06-30 | Macquarie University | Treatment of glaucoma |
| GB202102258D0 (en) * | 2021-02-17 | 2021-03-31 | Arecor Ltd | Novel composition |
| CA3205815A1 (en) * | 2021-03-03 | 2022-09-09 | Alwin REITER | Formulations of ace2 fc fusion proteins |
| CN113325181A (zh) * | 2021-04-25 | 2021-08-31 | 苏州市立医院(北区) | 丝氨酸蛋白酶抑制剂在用于脓毒症早期预警的标志物中的应用 |
| CN114874333B (zh) * | 2021-10-18 | 2025-01-24 | 深圳科兴药业有限公司 | 一种生长激素融合蛋白及其应用 |
| WO2023225513A1 (en) | 2022-05-16 | 2023-11-23 | Inhibrx, Inc. | Effective dosage of recombinant serpin-fc fusion protein for use in a method of treating aat deficiency in a subject |
| JP2026502133A (ja) * | 2022-12-22 | 2026-01-21 | ライフアーク | ガラニン－２受容体アゴニスト |
| EP4705336A1 (en) * | 2023-05-05 | 2026-03-11 | Paul Thomas King | Novel therapeutic polypeptide |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002537810A (ja) * | 1999-03-01 | 2002-11-12 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ヒトセルピンタンパク質 |
| US7317091B2 (en) * | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
| US7217797B2 (en) * | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| US7109172B2 (en) * | 2003-07-18 | 2006-09-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| DK2520654T3 (en) * | 2003-08-26 | 2017-05-01 | Univ Colorado Regents | Inhibitors of serine protease activity and their use in methods and compositions for the treatment of bacterial infections |
| US8802820B2 (en) * | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US9200079B2 (en) * | 2004-11-12 | 2015-12-01 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| NZ565511A (en) * | 2005-07-22 | 2011-03-31 | Five Prime Therapeutics Inc | Compositions and methods of treating disease with FGFR fusion proteins |
| WO2007021807A1 (en) * | 2005-08-12 | 2007-02-22 | Schering Corporation | Mcp1 fusions |
| WO2009158432A2 (en) * | 2008-06-27 | 2009-12-30 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
| JP5734201B2 (ja) * | 2008-12-19 | 2015-06-17 | マクロジェニクス，インコーポレーテッド | 共有結合型ダイアボディ及びその使用 |
| SG191233A1 (en) * | 2010-12-23 | 2013-07-31 | Janssen Biotech Inc | Active protease-resistant antibody fc mutants |
| LT2691417T (lt) * | 2011-03-29 | 2018-10-25 | Roche Glycart Ag | Antikūno fc variantai |
| SMT201900520T1 (it) * | 2011-06-28 | 2019-11-13 | Inhibrx Lp | Polipeptidi di fusione serpinici e relativi metodi d'uso |
| RU2639526C2 (ru) * | 2011-06-28 | 2017-12-21 | ИНХИБРКС ЭлЭлСи | Слитые полипептиды, содержащие домен wap, и способы их применения |
| KR20140137347A (ko) * | 2012-01-10 | 2014-12-02 | 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 | 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도 |
| MX2014015557A (es) * | 2012-06-21 | 2015-02-24 | Univ Indiana Res & Tech Corp | Polipeptidos de fusion de region fc de polipeptido de ligando receptor de incretina y conjugados con función efectora fc alterada. |
| KR20150030744A (ko) * | 2012-06-27 | 2015-03-20 | 에프. 호프만-라 로슈 아게 | 표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도 |
| CA2876096A1 (en) * | 2012-08-02 | 2014-02-06 | Petra Rueger | Method for producing soluble fcr as fc-fusion with inert immunoglobulin fc-region and uses thereof |
| EP2929045B1 (en) * | 2012-12-05 | 2020-12-02 | SOLA Biosciences LLC | Protein expression enhancing polypeptides |
-
2015
- 2015-10-27 MX MX2017005467A patent/MX2017005467A/es unknown
- 2015-10-27 CA CA2965151A patent/CA2965151A1/en active Pending
- 2015-10-27 SG SG10201903142RA patent/SG10201903142RA/en unknown
- 2015-10-27 IL IL251799A patent/IL251799B2/en unknown
- 2015-10-27 JP JP2017522654A patent/JP6737781B2/ja active Active
- 2015-10-27 AU AU2015339507A patent/AU2015339507B2/en active Active
- 2015-10-27 BR BR112017008525-9A patent/BR112017008525A2/pt active Search and Examination
- 2015-10-27 KR KR1020177014414A patent/KR20170091096A/ko not_active Ceased
- 2015-10-27 EP EP15854670.5A patent/EP3212290A4/en active Pending
- 2015-10-27 SG SG11201703390SA patent/SG11201703390SA/en unknown
- 2015-10-27 NZ NZ769391A patent/NZ769391A/en unknown
- 2015-10-27 KR KR1020237043666A patent/KR20240005109A/ko not_active Ceased
- 2015-10-27 WO PCT/US2015/057533 patent/WO2016069574A1/en not_active Ceased
- 2015-10-27 HK HK18103148.5A patent/HK1244460A1/zh unknown
- 2015-10-27 CN CN201580071331.7A patent/CN107206257A/zh active Pending
- 2015-10-27 RU RU2017118325A patent/RU2746550C2/ru active
- 2015-10-27 CN CN202111439584.9A patent/CN114316068A/zh active Pending
- 2015-10-27 UA UAA201705128A patent/UA127305C2/uk unknown
- 2015-10-27 IL IL308589A patent/IL308589A/en unknown
-
2017
- 2017-04-26 MX MX2021012047A patent/MX2021012047A/es unknown
-
2020
- 2020-07-16 JP JP2020121953A patent/JP2020180157A/ja active Pending
-
2021
- 2021-09-28 AU AU2021240153A patent/AU2021240153A1/en not_active Abandoned
-
2024
- 2024-05-29 AU AU2024203586A patent/AU2024203586A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017118325A (ru) | Слитые серпиновые полипептиды и способы их применения | |
| JP2024138397A5 (enExample) | ||
| NZ744257A (en) | Serpin fusion polypeptides and methods of use thereof | |
| JP6920230B2 (ja) | アルファ−１アンチトリプシン融合ポリペプチド、それをコードする核酸構築体、及びそれらの組成物 | |
| JP2022043042A5 (enExample) | ||
| JP6216921B2 (ja) | アルファ−１抗トリプシン融合分子のための組成物、方法および使用 | |
| JP2010524971A5 (enExample) | ||
| JP2018070625A5 (enExample) | ||
| CN113173995B (zh) | 一种结合冠状病毒的双特异性抗体 | |
| JP2023504914A5 (enExample) | ||
| CN104114574B (zh) | 结合人补体c5的多肽 | |
| JP2015504675A5 (enExample) | ||
| JP2012505902A5 (enExample) | ||
| JP6938565B2 (ja) | Ｕｔｉ融合タンパク質 | |
| JP2014530611A5 (enExample) | ||
| JP2018537087A5 (enExample) | ||
| JP2008507298A5 (enExample) | ||
| CN103396479A (zh) | α-1-抗胰蛋白酶和载脂蛋白A-I的纯化方法 | |
| JP2022509517A5 (enExample) | ||
| JP2007509984A5 (enExample) | ||
| JP2020019813A5 (enExample) | ||
| CN107226842B (zh) | 靶向pd-1的多肽及其应用 | |
| JP2022530742A5 (enExample) | ||
| JP2009507503A5 (enExample) | ||
| CN102690354A (zh) | 重组二聚化抗凝血酶III-Fc融合蛋白及其哺乳动物细胞高效表达系统 |